March 29, 2023
The Third Circuit on Wednesday revived an insurer's suit seeking to avoid paying $1.1 million in defense costs for a U.S. Securities and Exchange Commission investigation of a pharmaceutical company facing allegations its executives engaged in stock manipulation before the company came into existence, clearing the case for trial.